Cancer treatment guidelines
Oncology is a complex and rapidly changing field. Clinical guidelines assist physicians and patients in choosing the most appropriate standard of care. These guidelines may offer concise instructions on which diagnostic or screening tests to order, how to provide medical or surgical care, how long patients should stay in the hospital, or other details of conventional clinical practice.
The European Society for Medical Oncology’s Clinical Practice Guidelines summarise standard treatments per cancer type prepared and reviewed by oncology experts. Evidence-based medicine translates cancer research results into new standards and methods for clinical practice. The ESMO Clinical Practice Guidelines are designed to guide medical oncologists in the diagnosis, follow-up, and treatment of different cancer types and conditions.
ESMO guides for patients
Patient guides based on ESMO’s Clinical Practice Guidelines are available as well (in several languages), and some have been developed in cooperation with the Anticancer Fund. They are designed to help patients evaluate treatment options and translate complex medical information into a language understandable to every patient.
The Clinical Practice Guidelines in Oncology are developed by the American National Comprehensive Cancer Network (NCCN). These guidelines are a recognized standard for cancer treatment. They are intended to assist all involved in the clinical decision-making process, including physicians, nurses, patients and their families, with the ultimate goal of improving patient care and outcomes.
Personalised patient information
Patients can contact the ACF for relevant, detailed, up-to-the-minute information about a specific cancer type or treatment. Informing patients about their individual treatment options is part of our mission. This is a free service offered to patients and their families to help them understand the nature of their diseases and explore existing treatment options. We depend on donations to provide this independent and free service to patients and their family.
Our views on treating cancer
We invest in the most promising research to make measurable progress in the fight against cancer.
We strive to improve survival and quality of life, financial return is not within the scope of our activities.
We identify untapped potential in cancer research leading to pragmatic solutions for patients in need.
We seek impact and we invest our resources where we believe we can make the most progress.
Every cancer deserves the same attention, regardless of prevalence or profitability.